ReviewProceedings of the National Academy of Sciences of the United States of America2018

Tolerogenic nanoparticles restore the antitumor activity of recombinant immunotoxins by mitigating immunogenicity.

Ronit Mazor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.